Gelonghui, January 14 | Saixiang Technology (002337.SZ) issued an announcement. Based on full recognition of the future development prospects and long-term investment value of Tianjin Yuanshan Medical Technology Co., Ltd. (hereinafter referred to as “Yuanshan Medical”), Tianjin Haitai Haihe Biomedical Industry Fund Partnership (Limited Partnership) (hereinafter referred to as “Haitai Haihe Fund”) plans to increase the capital of Yuanshan Medical by 70 million yuan and subscribe for an additional registered capital of 9581,000 yuan. The company plans to increase Yuanshan Medical's capital by 30 million yuan and subscribe for an additional registered capital of 410,600 yuan. The deal was led by Haitai Haihe Fund, followed by Saixiang Technology. After the capital increase is completed, Haitai Haihe Fund will hold 3.3333% of Yuanshan Medical's shares, and Saixiang Technology will hold 1.4285% of Yuanshan Healthcare's shares.
赛象科技(002337.SZ)拟对远山医疗增资3000万元
Saixiang Technology (002337.SZ) plans to increase the capital of Yuanshan Medical by 30 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.